Want to hire this expert for a project? Request a quote for free.
Profile Details
Hire Dr. Sarah W.
United Kingdom
Neuroscience, neuroimaging & psychology background | Expertise in biomarkers & dementia
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing,
Newswriting
Research
Fact Checking,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Data Visualization
Work Experience
Biomarker Team Leader
University of Oxford
October 2017 - October 2018
Postdoctoral Scientist
University of Oxford
September 2014 - October 2017
Tutor for the Final Honour School of Medical Sciences, Experimental Psychology and Medicine
University of Oxford
September 2015 - September 2017
Research Worker
King's College London
October 2010 - February 2011
Education
PhD Psychological Medicine
King's College London
February 2011 - April 2014
MSc Cognitive Brain Imaging
University of Manchester
September 2009 - September 2010
BSc Psychology
University of Manchester
September 2006 - September 2009
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2018). Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result . Frontiers in aging neuroscience.
(2017). The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology . Alzheimer's research & therapy.
(2015). Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology . Frontiers in neurology.
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort . Journal of Alzheimer's disease : JAD.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort . Alzheimer's & dementia (New York, N. Y.).
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum . Alzheimer's & dementia : the journal of the Alzheimer's Association.
A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication . Journal of Alzheimer's disease : JAD.
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay . Alzheimer's & dementia : the journal of the Alzheimer's Association.
Blood protein predictors of brain amyloid for enrichment in clinical trials? . Alzheimer's & dementia (Amsterdam, Netherlands).
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly . Journal of Alzheimer's disease : JAD.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort . Alzheimer's & dementia : the journal of the Alzheimer's Association.
Inflammatory biomarkers in Alzheimer's disease plasma . Alzheimer's & dementia : the journal of the Alzheimer's Association.
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment . Journal of nuclear medicine : official publication, Society of Nuclear Medicine.